Skip to main content
Premium Trial:

Request an Annual Quote

Incyte, Baylor Announce Research Partnership


Incyte Genomics also said it had entered into a genomic research partnership with Baylor College of Medicine in Houston.

Under the terms of the agreement, scientists at Texas Children’s Cancer Center, a joint program of Baylor and Texas Children’s Hospital, will work with Incyte to conduct gene expression studies and determine the role of genes in the prevention, diagnosis, and treatment of cancers that commonly affect children.

Intellectual property resulting from this collaboration will be jointly owned by Baylor and Incyte and available for licensing through Incyte.

Incyte and Baylor scientists will design and conduct studies on gene and protein expression to examine the relationship of gene function to the progression and treatment of cancer.

Incyte will extract and analyze gene and protein expression data from Baylor’s biological samples for incorporation into the company’s LifeExpress gene expression database while Baylor will obtain access to Incyte’s LifeSeq Gold gene sequence database.

Filed under

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.